Skip to main content
    S

    Stryker Corporation (SYK)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $310.67
    +1.03 (+0.33%)

    Market Cap: $117.88B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Stryker Corporation (SYK) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Stryker are Boston Scientific (BSX), Medtronic (MDT) and Edwards Lifesciences (EW). Stryker trades at 21.8x earnings, against a median of 18.0x for the 9 of these companies with a P/E. By market cap, Stryker ranks 4th of the 13 companies on this page; Abbott Laboratories (ABT) is the largest at $187.95B.

    Peer Comparison

    SYK's ROIC of 11.4% is above the peer median of 7.5%, and its revenue growth of 7.6% is above the median of 7.4%. Its dividend yield is above the peer median of 0.27%.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Stryker (SYK)$117.88B21.8x4.5x13.8%11.4%7.6%1.13%
    Boston Scientific Corp (BSX)$64.27B13.7x3.0x16.6%10.2%1.4%0.00%
    Medtronic PLC (MDT)$131.57B18.0x3.5x13.9%7.5%13.7%2.80%
    Edwards Lifesciences Corp (EW)$61.61B36.4x9.2x15.3%7.5%10.5%0.00%
    Abbott Laboratories (ABT)$187.95B20.0x3.9x9.8%6.3%14.5%2.34%
    STERIS plc (STE)$25.67B24.1x4.1x13.4%9.4%8.8%1.05%
    GE HealthCare Technologies Inc. (GEHC)$37.54B16.9x1.7x9.9%11.9%7.2%0.19%
    Integra LifeSciences Holdings (IART)$1.12B5.5x0.7x0.8%2.1%2.3%0.00%
    Zimmer Biomet Holdings Inc (ZBH)$19.53B12.0x2.3x8.9%5.0%3.1%0.95%
    Smith & Nephew SNATS Inc (SNN)$13.09BN/A2.1x10.1%8.0%4.6%2.56%
    McKesson Corporation (MCK)$127.33B25.9x0.3x1.1%108.2%7.6%0.34%
    Si-Bone Inc (SIBN)$1.06BN/A4.8x-6.2%-6.0%14.5%0.00%
    Treace Medical Concepts Inc (TMCI)$345.50MN/A1.4x-27.4%-32.8%-3.9%0.00%
    Peer median$31.60B18.0x2.6x9.8%7.5%7.4%0.27%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Stryker, ranked by how closely their business, size, sector and industry match. The largest group, 11 of the 12, is in Medical Devices; the other one is in Medical Distribution.

    CompanyAboutPeers
    Boston Scientific Corp (BSX)Medical Devices
    Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties...
    BSX competitors
    Medtronic PLC (MDT)Medical Devices
    Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States.
    MDT competitors
    Edwards Lifesciences Corp (EW)Medical Devices
    Edwards Lifesciences is an American medical technology company headquartered in Irvine, California...
    EW competitors
    Abbott Laboratories (ABT)Medical Devices
    Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
    ABT competitors
    STERIS plc (STE)Medical Devices
    Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system.
    STE competitors
    GE HealthCare Technologies Inc. (GEHC)Medical Devices
    GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States.
    GEHC competitors
    Integra LifeSciences Holdings (IART)Medical Devices
    Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery...
    IART competitors
    Zimmer Biomet Holdings Inc (ZBH)Medical Devices
    Zimmer Biomet is a publicly traded medical device company.
    ZBH competitors
    Smith & Nephew SNATS Inc (SNN)Medical Devices
    Smith & Nephew plc develops, manufactures, markets and sells medical devices worldwide. The company is headquartered in Watford, the United Kingdom.
    McKesson Corporation (MCK)Medical Distribution
    McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies...
    MCK competitors
    Si-Bone Inc (SIBN)Medical Devices
    SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States...
    SIBN competitors
    Treace Medical Concepts Inc (TMCI)Medical Devices
    Treace Medical Concepts, Inc., an orthopedic medical device company, is dedicated to the design, manufacture...
    TMCI competitors

    Frequently Asked Questions About SYK

    Who are Stryker's main competitors?

    The companies most similar to Stryker include Boston Scientific (BSX), Medtronic (MDT), Edwards Lifesciences (EW), Abbott Laboratories (ABT) and STERIS (STE), listed from the closest match.

    Who is Stryker's biggest competitor?

    Abbott Laboratories (ABT) is the largest of the similar companies at $187.95B; Boston Scientific (BSX) is the closest match by business profile, size, sector and industry.

    How does SYK stock compare with its competitors?

    SYK's P/E is 21.8x against a peer median of 18.0x; its P/S is 4.5x against a peer median of 2.6x; its net margin is 13.8% against a peer median of 9.8%.

    Which of Stryker's competitors pays a higher dividend?

    Stryker has a forward dividend yield of 1.13%. Medtronic (MDT), Smith & Nephew SNATS (SNN) and Abbott Laboratories (ABT) have higher forward dividend yields; Medtronic (MDT) has the highest at 2.80%.

    Is Stryker bigger than its competitors?

    No. Stryker is 4th by market cap among the 13 companies on this page; the largest is Abbott Laboratories (ABT) at $187.95B.